Swine Flu Vaccines in 1976 Were Linked To Guillain-Barré Syndrome

Swine Flu Vaccines in 1976 Were Linked To Guillain-Barré Syndrome

Guillain-Barré syndrome is thought to be caused by a problem with the immune system, the body's natural defense against illness and infection. New neurologic symptoms is one of the reasons they stopped the J&J vaccines

Normally the immune system attacks any germs that get into the body. But in people with Guillain-Barré syndrome, something goes wrong and it mistakenly attacks the nerves.

This damages the nerves and stops signals from the brain traveling along with them properly, which can cause problems such as numbness, weakness and pain in the limbs.

It's not clear exactly why this happens. The condition is not passed from person to person and is not inherited.

In the past, the flu vaccine used in the US during a swine flu outbreak in 1976 were linked to an increased risk of Guillain-Barré syndrome.

Guillain-Barré symptoms

But research has since found the chances of developing the condition after having a vaccination are extremely small.

For example, a study into the vaccine used during the 2009 swine flu outbreak found that for every million people who had the vaccination, there were fewer than 2 extra cases of Guillain-Barré syndrome.

And evidence suggests that you are far more likely to get Guillain-Barré syndrome from an infection, such as the flu, than the vaccine designed to prevent the infection, such as the flu jab.

Guillain-Barré syndrome (GBS) is a rare disorder where the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis. While its cause is not fully understood, the syndrome often follows infection with a virus or bacteria. Each year in the United States, an estimated 3,000 to 6,000 people develop GBS. Most people fully recover from GBS, but some have permanent nerve damage.

In 1976, there was a small increased risk of GBS after swine flu vaccination, which was a special flu vaccine for a potential pandemic strain of flu virus. The National Academy of Medicine, formerly known as the Institute of Medicine, conducted a scientific review of this issue in 2003 and found that people who received the 1976 swine flu vaccine had an increased risk for developing GBS. The increased risk was approximately one additional case of GBS for every 100,000 people who got the swine flu vaccine. Scientists have several theories about the cause, but the exact reason for this link remains unknown.

There have been several studies of the risk of GBS after flu vaccine and CDC monitors for GBS during each flu season. The data on an association between seasonal influenza vaccine and GBS have been variable from season to season. When there has been an increased risk, it has consistently been in the range of 1-2 additional GBS cases per million flu vaccine doses administered.

Studies suggest that it is more likely that a person will get GBS after getting the flu than after vaccination. It is important to keep in mind that severe illness and death are associated with flu, and getting vaccinated is the best way to prevent flu infection and its complications.

Potential J&J Covid-19 Vaccine Symptoms

covid 19 vaccine symptoms

J&J COVID-19 Vaccine Update, April 13, 2021

The use of this vaccine is ‘paused’ for now. This is because the safety systems that make sure vaccines are safe received a small number of reports of a rare and severe type of blood clot happening in people who got this vaccine.

We do not know enough yet to say if the vaccine is related to or caused this health issue. To be extra careful, CDC and FDA recommend that the vaccine not be given until we learn more.

If you got this vaccine, seek medical care urgently if you develop any of the following symptoms:

  • severe headache
  • backache
  • new neurologic symptoms
  • severe abdominal pain
  • shortness of breath
  • leg swelling
  • tiny red spots on the skin (petechiae), or
  • new or easy bruising

A pause in the use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine. This means that CDC and FDA recommend this vaccine not be given to anyone until we know more. This gives scientists a chance to review the data and decide if recommendations on who should get the vaccine need to change. CDC and FDA will share more information as soon as possible with healthcare providers, people who got the vaccine, and the public.

From their review, they saw a small number of cases of a rare and severe type of blood clot in people who got the J&J/Janssen COVID-19 Vaccine. All reported cases were in women between the ages of 18 and 48, and the problems were found up to two weeks after vaccination.

How Much Money Did J&J Make From COVID Vaccines?

$1 Billion Deal for COVID vaccines

The company is on track to produce 1 billion doses for global distribution by the end of 2021, which would generate up to $10 billion. In August, Johnson & Johnson reached a more than $1 billion agreement with the United States for 100 million doses of its vaccine, with the option to purchase an additional 200 million doses, for $10 per shot. In addition, Johnson & Johnson reached an agreement with the E.U. for up to 400 million doses.

CDC and FDA have recommended a pause in the use of the Johnson & Johnson’s Janssen COVID-19 vaccine in the United States out of an abundance of caution, effective Tuesday, April 13. CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday, April 14, to address this issue. People who have received the J&J/Janssen COVID-19 vaccine within the past three weeks who develop severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider.

How Many People Got The J&J COVID Vaccine?

blood clot vaccine

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.

CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.

Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.htmlexternal icon.

CDC and FDA will provide additional information and answer questions later today at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.

How Much Does Big Pharma Spend on Advertising & PR?

TV Advertising Spending by Network in 2015 (Not accurate but you get the point)

News used to be separate from entertainment programs. Those rules were changed. New Zealand and the US are the only countries that allow pharmaceutical product ads on TV. Our news outlets are now majority funded by pharma. In another record year for pharma TV ads, more than 70% of advertising is spent by big pharma ($5B).


  
See the full list of the top 20 TV ad spenders below, courtesy of iSpot.tv
.
1. AbbVie’s Humira: $375 million
2. Pfizer’s Lyrica: $213 million
3. Pfizer’s Xeljanz: $209 million
4. Eli Lilly’s Trulicity: $183 million
5. Bayer and Johnson & Johnson's Xarelto: $143 million
6. Celgene’s Otezla: $139 million
7. Pfizer and Bristol-Myers Squibb's Eliquis: $136 million
8. Merck’s Keytruda: $107 million
9. Pfizer’s Ibrance: $92 million
10. Boehringer Ingelheim and Eli Lilly's Jardiance: $86 million
11. Otsuka and Lundbeck's Rexulti: $84 million
12. Eli Lilly’s Taltz: $83 million
13. Eli Lilly’s Verzenio: $80.4 million
14. Pfizer’s Prevnar 13: $79.9 million
15. Pfizer’s Eucrisa: $79.7 million
16. Sunovion’s Latuda: $78 million
17. Novo Nordisk’s Victoza: $78 million
18. AstraZeneca’s Farxiga: $75 million
19. Amgen’s Enbrel: $70 million
20. Novartis’ Cosentyx: $64 million

Here is a list of top 50 companies.  Why Istn't J&J On This List?

If you watch television for any amount of time, you’re probably going to see a drug commercial that tugs on your heart strings, promises to heal your worst medical conditions, and then a voiceover will quickly gloss over the multitude of side effects in a too-quick-to-understand string of monotone words. Prescription medications are are multi-BILLION dollar industry that’s making not only the pharmaceutical companies tons of money, but also the network television stations. How is this influencing public opinion AND health?

Are you annoyed yet how much these ads are on TV?   Equally concerning is that pharmaceutical advertising is banned in just about every country except the United States and New Zealand. And consider this: the average American watches 16 hours of pharmaceutical commercials each year which is more time than they spend with their primary physician. One-third of these people ask their doctors about a drug advertisement and most request a prescription.

Are any these companies responsible for the negative PR campaigns to smear Dr. Judy Mikovitz theory PhD Scientist "A Vaccine Could Be Causing The Covid-19 Pandemic"?  All of these debunking articles are trying to discredit Judy's reputation and none of them really are answering the true questions that she raises.


If you enjoyed this article you also might like to read these articles: 


Can We Really Develop a Safe, Effective Coronavirus Vaccine?

We don’t know for sure, but if we can, it probably won’t be easy, cheap or fast

In the event of any infectious disease outbreak, our minds turn to vaccines and they do so for good reason. They can safe in most cases, relatively expensive and have worked pretty well for diseases including smallpox, polio, yellow fever, and, most recently, Ebola.

Scientists suggest the Coronavirus has already mutated into 30+ strains.  Drug and vaccine development, while urgent, need to take the impact of these accumulating mutations into account to avoid potential pitfalls.  Researchers said the findings show the true diversity of the viral strains is still largely underappreciated.

Also, many scientists think this might make it difficult for a vaccine that’s created in a year from now.  It might not be the vaccine that’s effective because it won’t be targeting the right molecule, and it’s targeting could change a little bit.

The CDC used to cite that the flu vaccine was 70-90% effective from 2004-2016. I was quite surprised to see this chart below when I looked at the CDC web site showing 10-60% effectiveness. Clinical Infectious Disease Flu Vaccine
Real-time tracking of pathogen evolution. Nextstrain is an open-source project to harness the scientific and public health potential of pathogen genome data. We provide a continually-updated view of publicly available data alongside powerful analytic and visualization tools for use by the community. Our goal is to aid epidemiological understanding and improve outbreak response.

Will a vaccine come as easily for the novel coronavirus? The answer is maybe yes, maybe not. The “maybe yes” comes from the observation that in animal studies, coronaviruses stimulate strong immune responses, which seem capable of knocking out the virus. Recovery from COVID-19 may be in large part due to effective immune response. The “maybe not” comes from evidence just as strong, at least with earlier SARS and MERS viruses, that natural immunity to these viruses is short-lived. In fact, some animals can be reinfected with the very same strain that caused infection in the first place.

This raises more crucial questions with equally ambiguous answers. If a vaccine does prove to be effective, would it be effective for long?  How long will it take to develop a vaccine in the first place?  Will herd immunity be more effective?  Did Sweden get it right with regards to public policy?

Here is an Example of How the Flu Virus Can Change: “Drift” and “Shift” from CDC.  Influenza viruses are constantly changing. They can change in two different ways and thus why flu vaccines are not always effective.

One way influenza viruses change is called “antigenic drift.”  The small changes that occur from antigenic drift usually produce viruses that are closely related to one another, which can be illustrated by their location close together on a phylogenetic tree. Influenza viruses that are closely related to each other usually have similar antigenic properties. This means that antibodies your immune system creates against one influenza virus will likely recognize and respond to antigenically similar influenza viruses (this is called “cross-protection”).

However, the small changes associated with antigenic drift can accumulate over time and result in viruses that are antigenically different (further away on the phylogenetic tree). It is also possible for a single (or small) change in a particularly important location on the HA to result in antigenic drift. When antigenic drift occurs, the body’s immune system may not recognize and prevent sickness caused by the newer influenza viruses. As a result, a person becomes susceptible to flu infection again, as antigenic drift has changed the virus enough that a person’s existing antibodies won’t recognize and neutralize the newer influenza viruses.

Antigenic drift is the main reason why people can get the flu more than one time, and it’s also a primary reason why the flu vaccine composition must be reviewed and updated each year (as needed) to keep up with evolving influenza viruses.

The other type of change is called “antigenic shift.” Antigenic shift is an abrupt, major change in an influenza A virus, resulting in new HA and/or new HA and NA proteins in influenza viruses that infect humans. Shift can result in a new influenza A subtype in humans. One way shift can happen is when an influenza virus from an animal population gains the ability to infect humans. Such animal-origin viruses can contain an HA or HA/NA combination that is so different from the same subtype in humans that most people do not have immunity to the new (e.g., novel) virus. Such a “shift” occurred in the spring of 2009, when an H1N1 virus with genes from North American Swine, Eurasian Swine, humans and birds emerged to infect people and quickly spread, causing a pandemic. When shift happens, most people have little or no immunity against the new virus.

While influenza viruses change all the time due to antigenic drift, antigenic shift happens less frequently. Influenza pandemics occur very rarely; there have been four pandemics in the past 100 years. For more information, see pandemic flu. Type A viruses undergo both antigenic drift and shift and are the only influenza viruses known to cause pandemics, while influenza type B viruses change only by the more gradual process of antigenic drift.

The history of vaccines also shows that Government policies based around mandating vaccines are political

You might also enjoy this article: Why We Need a Placebo Covid-19 Vaccine

Why We Need a Placebo Covid-19 Vaccine

mind over matter vs vaccine
Mind over matter is a very real phenomenon in medicine. 

A clinical placebo is a treatment that has no intended therapeutic effect. In a clinical trial, a placebo could be a saline formulation that is typically inert when injected. Or, the placebo could be the formulated mix of salts and leftover impurities that are present with the vaccine under investigation minus the active ingredient (vaccine).

In using a placebo while testing vaccine trials investigators want to eliminate any thoughts, views, emotions, and expectations as much as possible. Study participants will not know (they will be blind) to what treatment they receive, and often so will most of the investigators (double-blind). 

The key objective of a placebo is to allow the participant to believe they have received the medicine being tested. The placebo effect is a beneficial health outcome resulting from a person’s anticipation that an intervention will help. How a health care provider interacts with a patient also may bring about a positive response that’s independent of any specific treatment.

It is my view that if we had a more positive outlook on the likelihood that you will be just fine if you get the virus and treat it properly than we would all be living happier lives.  Having more people believe they have taken a Covid-19 vaccine might have an amazingly positive effect on society.  

What is the nocebo effect?

Scary health stories about COVID-19 pour out of the media floodgates every minute. These might be causing “nocebo effects” – where we become more ill because we expect to, as opposed to the better-known placebo effect where we become less ill due to our expectations. This could be happening on a large scale just now. 

We are understanding more and more about how nocebo effects work. Emotionally charged negative information from an authoritative source can make someone expect a negative symptom such as pain or breathlessness. Then, like a self-fulfilling prophecy, the expectation itself can cause the symptom. These expectations are associated with the production of neurotransmitters that induce an increased sensitivity to pain and a wide variety of other symptoms. Fear and anxiety heighten this process.
nocebo effect
A fascinating study examined the impact of the placebo effect in 84 trials of nerve pain treatments that took place over the prior 23 years. The researchers found that the placebo effect has become remarkably stronger, but this observation was only noted in U.S. studies. Why? One theory is that the flood of direct-to-consumer drug advertising in the U.S. (which is not allowed in most other countries) increases patients’ expectations that medication will help them. Stronger and higher expectations of a drug’s effectiveness may translate into a bigger placebo effect.  

If you enjoyed this article you also might like to read these two articles: 

The Balancing Act of Herd Immunity - Wealth vs Health

Harvard Suggest Intermittent Social Distancing Could Be More Effective

Harvard University researchers say an on-again, off-again approach to social distancing could be a more effective strategy to avoid overwhelming hospitals and to build herd immunity against the novel coronavirus — but other experts aren’t so sure.

An April study, conducted at Harvard University’s T.H. Chan School of Public Health, championed intermittent social distancing — measures that are periodically reimposed when cases reach certain levels.

According to the researchers’ modelling, as long as social distancing occurred between 25 per cent and 75 per cent of the time, the world could both build immunity and keep the health-care system from overloading.  Watch the video on this page.

Social distancing restrictions could be eased under various scenarios, according to the authors—if COVID-19 treatments become available, if hospitals can increase their intensive care bed capacity, if there’s aggressive contact tracing and quarantine, or if a vaccine is developed.
“I think social distancing interventions of some sort are going to have to continue, hopefully lightened and in conjunction with other interventions,” said Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics and co-senior author of the study, in an April 14 article in STAT.

Here is a video explaining how the no lockdown strategy and accelerated "herd immunity" might be working in Sweden but also explains the risks.   Sweden prefers to use the term "transmission" for fear that they are perceived as giving up on fighting the disease.  Sweden's strategy would mean their death toll will be higher earlier and lower later as herd immunity achieved.  Thus, Sweden would not likely experience a second wave of transmission in the fall and winter months.   



It also raises the question of how many people are actually following the stay at home orders
Here is a Twitter poll asking if Intermittent social distancing would be effective? 

These 2 Flu Vaccines Are Killing People in South Korea

SINGAPORE - Health authorities have advised against the use of two influenza vaccines - SKYCellflu Quadrivalent and VaxigripTetra - after people who received them in South Korea died.

No deaths associated with influenza vaccination have been recorded here, noted the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Sunday (Oct 25), adding: "This is a precautionary measure following reported deaths after influenza vaccination in South Korea."

Information from South Korean authorities noted that seven brands of influenza vaccine had been administered to the people who died in South Korea.

Two of the seven brands are available in Singapore: SKYCellflu Quadrivalent is manufactured by SK Bioscience and distributed here by AJ Biologics; VaxigripTetra is made by Sanofi Pasteur and locally distributed by Sanofi Aventis.

The HSA is assessing the implications of the reported deaths in South Korea and the MOH has told healthcare providers and medical practitioners to temporarily stop using the two vaccines.

But the two other vaccines that have been brought into Singapore for the influenza season can still be used, they added.

ike any medicines, vaccines can cause side effects, such as soreness and redness at the injection site, fever, headaches, muscle aches, fatigue and nausea.

"These side effects are generally mild and resolve on their own. In rare instances, a person may experience high fever or severe allergic reactions (such as breathing difficulty, wheezing and swelling around the eyes) and immediate medical attention should be sought," said the agencies.

They added that vaccines approved for use here have been evaluated by the HSA to ensure that they meet the required international standards of quality, safety and efficacy.

The HSA monitors vaccine safety through a monitoring system that draws on the network of local healthcare professionals and international regulatory counterparts to pick up adverse events suspected to be associated with the medications.

Related Articles

Seeking Journalist Interviews On The Social Media Fake News Landscape

fake news

We are looking for videographers to film exclusive interviews with world-famous journalists to talk about how do they think of the global media landscape in this new era. 

With social media’s development and prosperity, traditional media is facing a series of challenges. For instance, people are getting used to reading news on social media even they might get mislead by some fake news. Moreover, media has also be politicalized or might be taken advance of by certain politicians to serve their own needs. With the whole internet environment changing in this new era, traditional media has also changed a lot. So we would like several famous journalists to talk about the opportunities and challenges faced by traditional media.


Here are some questions we would like to ask:


1.How has COVID-19 changed the global media landscape in 2020?


2.People rely more on social media and other platforms for news, some of which is misleading or simply false. What do you think of this phenomenon? What should journalists do to change this?


3.Now that many people do not trust traditional media, is journalistic professionalism facing a crisis?


4.What do you think of the information cocoon room?


We would like you to find some famous journalists who have a say in this field.

Here is a list of top journalists for you to refer:

https://www.nyfa.edu/student-resources/top-12-influential-journalists-today/

You are also welcome to suggest other appropriate journalists.


The interview could be an in-person or Skype interview.  If you have existing footage, please select ‘filmed’ in the Footage Types and upload them or share links with us. Then we will evaluate the materials you submit to us before deciding whether to commission your pitch. 


Apply as soon as possible to increase your chances of getting commissioned. If selected, you will receive an email from us and a producer will get in touch with you. Not available? Then refer someone to us by forwarding this assignment to a friend. 


Best, 


Pear Video


Location:Worldwide


Application Deadline:2021-01-23


Apply here https://stringer.pearvideo.com/pitch/postPitch?taskId=459 if you are interested and available.


If you have existing footage, please select 'filmed' in the Footage Types and upload them or share links with us. Then we will evaluate the materials you submit to us before deciding whether to commission your pitch.


Apply as soon as possible to increase your chances of getting commissioned. If selected, you will receive an email from us and a producer will get in touch with you. Not available? Then refer someone to us by forwarding this email to a friend.


Thank you!



Best,


Pear Video


---------

Disclaimer: This communication contains information from Shanghai Pear Video Internet Technology Co., Ltd. that may be confidential. Except for personal use by the intended recipient or as expressly authorized by the sender, any person who receives this information is prohibited from disclosing, copying, distributing, and/or using it. If you have received this communication in error, please immediately delete it and all copies, and promptly notify the sender via world@pearvideo.com.

Popular Posts

Topics

Activist Advertising Air Quality Alchohol Antibody Antitrust Apple Apps Arizona Bankruptcy Banks Bars BBB Beaches Ben Shapiro Biden Big Pharma Bill Gates Blackmail blood clots Business California Cares Act CDC Censorship Chart Children China Class Action Closures CNN Contact Tracing Corruption Cover Up Data Deaths Doctors DOJ Dominion Drugs Education Election Elon Musk Email Enforcement Facebook Fake Laws Fake News Fake Tests Fake Vaccine False Positive Famotidine Fauci FBI FDA Fear Mongering Federal Reserve Feds Fines Florida Flu Flu Shots Fox Fraud Free Speech Freedom FTC Gavin Newsom Genome Glenn Beck Google Government Guillain-Barré Halloween Harvard Health Department Healthcare Herd Immunity Hospitals Hydroxychloroquine Insurance Investment IRS J&J Jeff Bezos Jobs LA County Lawsuits Leadership Lies Loans Local Laws Lockdown Los Angeles Map Masks Media Medicaid Melatonin Mental Health Michigan Minnesota Nashville New Jersey New York NFL Nursing Homes NY Post Opinion Opposing View Oppression Outdoors Parks Pennsylvania Phishing Placebo Pneumonia Politics Poll Pollution PPP Prevention Project Veritas Protest Rand Paul Real Estate Regeneron Relief Checks Remdesirvir Restaurants Restraining Order Rudy Giuliani Safegraph SBA Scams Schools Science Seniors Sidney Powell Social Distancing South Korea Sports Stadiums Stay at Home Study Substance Abuse Surveillance Sweden Symptoms Taxes Technology Testing Tips Tony Bobulinski Transmission Treatment Trojan Horse Trump Tucker Carlson Twitter Tyranny Unemployment Vaccine Video Vitamin D Warren Buffett Whistleblower WHO Wisconsin Workers Comp Zinc